Best PET-CT with 68 (DOTA) diagnosticians in Turkey: TOP 45 doctors

Place and Date of Birth: 08.12.1983 / ANKARA

Nationality: T.R.

Marital Status: He is married and has 1 child.

Foreign Language: English

Education

•Hamdullah Suphi Tanrıöver Primary School/Istanbul

• Karşıyaka Anatolian High School/İzmir

•Gülhane Military Medical Academy (2001 – 2007)

•Haydarpaşa Numune Hospital Orthopedics Clinic – Specialization (2012-2018)

Professional Experience

•Sahra Medical School Samsun (2007-2008)

•Ankara Gendarmerie Logistics Command Dispensary (2008-2010)

•Üsküdar Private Yunus Emre Hospital Emergency Physician (2010-2012)

•Haydarpaşa Numune Hospital Orthopedics Clinic (2012-2018)

•Şanlıurfa Suruç State Hospital (2018-2019)

•Np Istanbul Brain Hospital Orthopedic Specialist – Surgical Branch Specialist Medical

Deputy Director (2019- December 2020)

Medipol University Pendik Hospital (2020 -)

Member of Scientific Organizations

• Chamber of Physicians

• Turkish Orthopedics and Traumatology Association

• Turkish Industry and Business Association

• Robotic Knee Surgery Association

Scientific Studies

• Prevalence of metabolic syndrome and frequency of cardiovascular risk factors in obese children M.Emre Taşcılar , Bülent Hacıhamdioğlu , Mehmet Soyarslan, Ayhan Abacı

(Gülhane Medical Journal 2010;52 :32-35)

• Determination of the hip rotation centre from landmarks in pelvic radiograph Hasan Bombacı, Bestami Şimşek, Mehmet Soyarslan Murat Yıldırım (Acta orthopaedica et traumatologica turcica 51(6) October 2017)

• Compartment syndrome secondary to Baker’s cyst rupture: A case report and up-todate review Serkan Erkuş, Mehmet Soyarslan, Özkan Köse, Önder Kalenderer

(International Journal of Critical Illness and Injury Science 9(2):82 April 2019)

• Cutibacterium Acnes (Formerly Propionibacterium Acnes) Incidence In Shoulder Arthroscopy and Correlation with the Clinical Status Mehmet Soyarslan, Mehmet Kerem Canbora, Özkan Köse (HNH Medical Journal January 202

• 25. National Orthopedics and Traumatology Congress (2015)

1) Comparison of open and closed surgery in pediatric supracondylar humerus fractures (Poster)

2) What affects the clinical outcome most in open tibia fractures?

Is it the type of treatment chosen or the extent of the damage? (Poster)

3) Does lateral epicondylitis affect grasp strength? (Oral statement)

• 26. National Orthopedics and Traumatology Congress (2016)

1) Detection of hip rotation center in the pelvis X-ray of adult Turkish individuals (Poster)

• Hasan Bombaci* , Bestami Simsek, Mehmet Soyarslan, Mustafa Murat Yildirim, Determination

of the hip rotation centre from landmarks in pelvic radiograph, Acta Orthopaedica et

Traumatologica Turcica, Available online 10 October 2017, doi:

https://doi.org/10.1016/j.aott.2017.09.004

• 38. SICOT World Congress (Cape Town/South Africa 2017)

1) P.acnes Insidence In Shoulder Arthroscopy and Correlation With The Clinical Results

(Poster)

• 27. National Orthopedics and Traumatology Congress (2017)

1) “Propionibacterium acnes” Incidence and Clinical Reflections in Tissue Cultures Taken in Shoulder Arthroscopy

(Oral statement)

• 28. SECEC-ESSE Congress (Geneva/Switzerland 2018)

1) P.acnes Insidence In Shoulder Arthroscopy and Correlation With The Clinical Results

(Oral statement)

• 28. National Orthopedics and Traumatology Congress (2018)

1) Is hip flexion effective on respiratory and hemodynamic parameters of patients who underwent shoulder arthroscopy in the sitting position? (Oral statement)

2) Our Conventional Titanium Plate and PEEK Plate Applications in Multipartite Upper End of Humerus Fractures in Patients aged 55-70 years who were treated with Surgery: Is There a Radiological and Clinical Difference? (Oral statement)

• 10. Shoulder and Elbow Surgery Congress (2018)

1) “P.acnes” Incidence and Clinical Results in Shoulder Arthroscopy: Our Conventional Titanium Plate and PEEK Plate Applications in Multipartite Upper End of Humerus Fractures in Patients aged 55-70 years who were treated with Glenohumeral Joint and Surgery: Is There a Radiological and Clinical Difference? (Oral statement)

2) Evaluation of the Diagnostic Value of the Pain Chart in the Pathologies of the Shoulder in Patients Undergoing Arthroscopic Surgery (Poster)

• 1. Digital Shoulder Elbow Surgery Association Congress (2020)

1) Are the Size of Bone Loss and Number of Anchors Effective in Clinical Results and Failure after Arthroscopic Bankart Repair of Recurrent Shoulder Dislocations?

(Oral statement)

2) K-wire migration into the spinal canal after acromioclavicular dislocation surgery: Case

Presentation (Poster)

VI- Courses

• Training Course of Emergency Medicine Trainer (2007)

• PEV DDH (Developmental Hip Dysplasia and Pes Echinovarus) Course (2016)

• Basic Arthroscopy Course (2016)

• Turkish Orthopedics and Traumatology Education Council Basic Sciences School (2016)

• Acıbadem University Tibia Fractures Cadaver Course (2017)

• Bone and Soft Tissue Tumors Basic Course (2017)

• Knee Joint Arthroscopy and Foot - Ankle Surgical Interventions Applications Cadaver Courses (2017)

• Acıbadem University Advanced Knee Peripheral Sports Injuries Cadaver Course(2018)

• LIMA Corporate Shoulder Surgery Cadaver Course Verona/Italy (2018)

• Gazi University Ankle Arthroscopy Cadaver Course(2019)

• Antalya University Knee Arthroscopy Cadaver Course (2019)

• Antalya University Ankle Arthroscopy Cadaver Course (2019)

• Basic Microsurgery Course – Ankara (2019)

• Antalya University Wrist Arthroscopy Cadaver Course (2019)

Experience

2017 - 2020 Acıpayam State Hospital

2016 - 2017 Izmir Public Health Laboratory

2013 - 2016 Bozyaka Training and Research Hospital

2011 - 2013 Pendik State Hospital

2011 - 2011 Midyat State Hospital

2004 - 2010 Dokuz Eylul University Faculty of Medicine

Acipayam State Hospital

Izmir Public Health Laboratory

Bozyaka Training and Research Hospital

Pendik State Hospital

Midyat State Hospital

Dokuz Eylul University Faculty of Medicine

Education

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2004 Ege University, Faculty of Medicine

2004 Ege University, Faculty of Medicine

Publications

ARTICLES PUBLISHED IN INTERNATIONAL REFEREED JOURNALS

Bulent Ertugrul, Çağrı Buke, Özlem Saylak Ersoy, Bengisu Ay, Dilek Senen Demirez, Öner Savk. Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey. Diabetic foot and ankle.6: August 2015

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. Journal of Diabetes and its Complications, Volume 30, Issue 5, July 2016,910-916

Alpay Arı, Ali Ilgın Olut, Bengisu Ay, Selma Tosun, Meltem Zencir, Mehmet Umut Çayıröz. A small outbreak of Serratia liquefaciens bacteremia due to use of contaminated saline infusion solution for myocardial perfusion scintigraphy. Journal of Infectious Diseases, Volume 49, 2017, 639-40

B- PAPERS PRESENTED IN INTERNATIONAL SCIENTIFIC CONFERENCES AND PUBLISHED IN PROCEEDINGS

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Bacterial Etiology And Antimicrobial Resistance In Dfıs; A Multicenter Prospective Trial Of “Turk-Day”. Congress of Balkan Millitary Medical Committee, 8-11 June 2015, Greece

C- ARTICLES PUBLISHED IN NATIONAL REFEREED JOURNALS

VildanAvkan Oğuz, Bengisu Ay, Vasfi Karatosun, Zeynep Gülay; A Case of Total Knee Arthroplasty in which Aeromonas Hydrophila Was Isolated in Perioperative Culture: Trakya Univ Medical Faculty Journal, 2009

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group recommended for influenza vaccination. Medical Journal of İzmir Hospital 2013; 17 (4): 241-245

B Ay, S Calik, B Karaca, S Tosun. Atypical Mediterranean spotted fever: First case from Aegean Region. Izmir Tepecik Education and Research Hospital Journal. 2016; 26(2):175-177

B Ay, E Ozdemir, N Unel, S Calik, B Karaca. Telbivudine-Related Myopathy: A Case Report. Viral Hepat J 2016; 22: 37-38

D- PAPERS PRESENTED IN NATIONAL SCIENTIFIC MEETINGS AND PUBLISHED IN PROCEEDINGS

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group who are recommended to receive influenza vaccination. 5th National Vaccine Symposium, 25-29 September 2013, Ankara

''Evaluation of 4 Patients Receiving Telaprevir for Chronic Hepatitis C'' “Speech 7" Istanbul – Marriott Asia Hotel; 'Our Turkey Teleprevir Experience Symposium, 21 September 2013'

Bengisu Ay, Alpay Arı, Nalan Ünel, Erman Özdemir, Selma Tosun; Our experience with telaprevir in two centers: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Bengisu Ay, Erman Özdemir, Nalan Ünel; Myopathy side effect of telbivudine treatment due to a case: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Gülsüm Altın, Aslı Keleş, Bengisu Ay, Ebru Dik, Meltem Zencir, Halil Erkan, Selma Tosun. Evaluation of the differences and knowledge levels of individuals in the society about the transmission routes of Hepatitis B virus. BUHASDER 6. Tepecik Infection Days Symposium. 04-08 November 2015 Muğla.

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Causative Microorganisms and Antimicrobial Susceptibilities in Diabetic Foot Infection; A Multicenter Study “TURK-DAY”. 5th EKMUD Scientific Platform, 01-04 April 2015, İzmir.

Experience

2017 - 2019 Okan University Hospital

2019 - Medipol University Pendik Hospital

Education

2016 Marmara University Faculty of Medicine, Chest Diseases

2007 St. Cyril and Methodius University, Faculty of Medicine

Publications

1- Frequency of Immunodeficiency in Adult Non-Cystic Fibrosis Bronchiectasis Patients; Specialization Thesis

2- Canan Cimşit, Melahat Bekir, Sait Karakurt, Emel Eryüksel, Ultrasonographic evaluation of diaphragm thickness in COPD – Marmara Medical Journal 2016; 29:8-13

3- Emel Eryuksel, Canan Cimsit, Melahat Bekir, Çagatay Cimsit, Sait Karakurt, Diaphragmatic Thickness Fraction in Subjects at High Risk for COPD Exacerbations Respiratory Care December 2017

4- Melahat Bekir, T. Bahadır Üskül, Pulmonary Functions in Patients With Idiopathic Scoliosis The Journal of Turkish Spinal Surgery ; April 2017

5- Emel Eryuksel, Canan Cimsit, Melahat Bekir, Cagatay Cimşit, Sait Karakurt, Is Diaphragmatic Thickness fraction valuable in Identifying High-Risk Chronic Obstructive Pulmonary Disease Patients, European Respiratory Journal Sep 2017

6- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Berrin Ceyhan, The Effect of Clinical Findings on One-Year Disease Course in Adult Bronchiectasis Patients Other Than Cystic Fibrosis, 21st Annual Congress of the Turkish Thoracic Society _ Belek, Turkey 2018

7- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli Derya Kocakaya, Emel Eryüksel, Elif Karakoç Aydıner, İsmail Öğülür, Berrin Bağcı Ceyhan, Quality of Life in Adult Bronchiectasis Patients Other Than Cystic Fibrosis: The Role of Psychological Status and Disease Severity 20th Annual Congress of the Turkish Thoracic Society – Belek Türkiye 2017

8- Berrin Ceyhan, Melahat Bekir, Şehnaz olgun Yıldızeli, Derya Kocakaya , Emel Eryüksel, Validity and reliability of the Turkish version of the EMBARC (European Bronchiectasis Audit and Research Collaboration) quality of life scale in patients with non-cystic fibrosis bronchiectasis. Turkish Thoracic Society 20th Annual Congress – Belek, Turkey 2017 (POSTER AWARD WINNER)

9- Melahat Bekir, Şehnaz Olgun Yıldizeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Beyhan, Relationship Between Vitamin D Levels and Lung Functions, Clinical Indexes, Anxiety-Depression Symptoms in Adult Non-Cystic Fibrosis Bronchiectasis Patients – 19th Annual Congress of the Turkish Thoracic Society - Belek, Turkey 2016

10- Melahat Bekir, Derya Kocakaya, Şehnaz Olgun, Berrin Bağcı Ceyhan, Anticoagulant Treatment Approach in a Case of Venous Thrombosis Causing Superior Vena Cava Syndrome with Active Bleeding – 18th Annual Congress of the Turkish Thoracic Society – Belek, Turkey 2015

11- Melahat Bekir, Berrin Bağcı Ceyhan, Life-Threatening Bleeding After Anticoagulation with Rivaroxaban: Two Case Reports, 18th Annual Congress of the Turkish Thoracic Society – Belek, Turkey 2015

12- Şehnaz Olgun Yıldızeli, Çagatay Nuri Cimşit, Semiha Emel Eryüksel, Canan Cimşit, Melahat Bekir, Tuğçe Yakut, The Relationship of Pulmonary CT Angiography with Clinical Scores in Pulmonary Embolism – Turkish Thoracic Society 18th Annual Congress – Belek Turkey 2015

13- Melahat Bekir, Canan Cimşit, Hüseyin Arıkan, Derya Kocakaya, Şehnaz,Olgun, Semiha Emel Eryüksel, Sait Karakurt, Diaphragm Thickness in COPD Patients and Its Relationship with Symptoms, Turkish Thoracic Society 17th Annual Congress – Belek, Turkey 2014

14- Melahat Bekir Külah, Frequency of Immunodeficiency in Patients with Non-Cystic Fibrosis Bronchiectasis and its Relationship with Clinical Parameters, 20th Annual Congress of the Turkish Thoracic Society – Belek Türkiye 2017

15- Berrin Ceyhan, Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, One Year Follow-Up of Respiratory Health Outcomes in Adult Patients with Non-Cystic Fibrosis Bronchiectasis ERS 2018

16- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Emel Eryüksel, Elif Karakoç, İsmail Öğülür Berrin Bağcı Ceyhan Immun Deficiency in Patients with Non Cystic Fibrosis Bronchiectasis and Relationship with Clinical Parameters ATS Conference 2017- Washington, DC 2017

17- Melahat Bekir Külah, Sehnaz Olgun Yildizeli, Derya Kocakaya, Emel Eryuksel, Berrin Bagci Ceyhan Health Related Quality of Life Among Adult Patients With non Cf Bronchiectasis: The Role of Psychological status and disease severity ERS International Congress 2017, Milan Italy 2017

18- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Ceyhan The Relationship Between Vitamin D Level and Lung Function, Severity and Clinical Indices, Depression and Anxiety Symptoms in Adult Patients With Non-Cystic Fibrosis Bronchiectasis ATS Conference 2016 - San Francisco , California 2016

Experience

2016 - 2019 Private Gebze Konak Hospital

2014 - 2015 Private Medicana Camlica Hospital

2013 - 2014 Private Batman Hospital

2011 - 2013 Batman Regional State Hospital

Uskudar University

Gazi University Faculty of Medicine

Education

2011 Bezmialem Vakıf University Faculty of Medicine, Physical Medicine and Rehabilitation

2005 Marmara University, Faculty of Medicine in English

Pediatric Cardiology

Pendik Medipol University Hospital

Experience

2021 Private Nisa Hospital

2020 – 2021 Bezmialem Foundation University Faculty of Medicine

2015 – 2021 Bezmialem Foundation University Faculty of Medicine

2010- 2015 Izmir Dr. Behçet Uz Pediatric Training and Research Hospital

2008 – 2009 Gata Pediatric Cardiology 

1999 – 2003 Merzifon Aviation Medicine Center

Education

2006 Gülhane Military Medical Academy, Pediatric Cardiology

1998 Gülhane Military Medical Academy, Child Health and Diseases

1991 Gülhane Military Medical Academy, Faculty of Medicine

Gastroenterology

Pendik Medipol University Hospital

Education

1999 Karadeniz Technical University, Gastroenterology

1997 Atatürk University, Internal Diseases Professorship

1992 Atatürk University, Internal Diseases Associated Professorship

1985 Atatürk University, Internal Diseases Specialist

1981 Atatürk University Faculty of Medicine

Publications

1- Nihat Okçu Gülçin Polat, Arif Yılmaz, Mehmet Koruk, The demographic features of gastric cancers in Erzurum(Eurasian J Med 2000; 32: 63-65)

2- An Evaluation of Upper Gastrointestinal Bleeding Cases. Clinical Sciences-Doctor.2000, - E.akarsu,N.Okçu,et Ark.Northeast Anatolia 6:4:435-438

3-N.Okçu, A.yılmaz. İ.kiki,MDonuk, C.gündoğdu, H.uzunismail. Our Diagnostic Upper Gastrointestinal Endoscopy Results. Atatürk University Medical Journal 1997,29 (2):486

4-N. Okçu, M.gündoğdu, MD onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, I. çapoğlu. The Role of Misoprostol in Preventing Gastroduodenal Lesions in Patients Using Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Atatürk University Medical Journal 1997,29 (2):453-455.

5-N.Okçu, A. Öz, MD Onuk, E.Akarsu, B. Tekin, Hz Tonbul, H.Kaya. Plasma Fibronectin Levels in Chronic Active Hepatitis and Decoction of Liver Parenchymal Insufficiency and Their Relationship with Liver Functional Status. Turkish J. Gastroenterol 1995;27(4): 422-426.

6-N.Okçu, Tahir Buran, MD Onuk, A. Yılmaz, E.Akarsu, G. Akçay. Prevalence of Helicobacter Pylori in Patients with Duodenal Ulcer in Erzurum and Surrounding Area. Turkish J. Gastroenterol 1995;27(4): 447-450.

7-N.Okçu, bs awake, e. akarsu, e. bakan, z. tonbul. Importance of Carbohydrate Antigens (CA-19-9, CA-125), Carcinoembryonic Antigen (CEA) and Alkaline Phosphatase in Gastric and Colorectal Cancers. Turkish J. Gastroenterol 1995;6:467-471.

8-N. Okçu, MD Onuk, E. Akarsu, H. Doğan, C. Gündoğdu. Major Risk Factors in Patients with Hepatocellular Carcinoma in Our Region. Gastroenterology 1994;5(2):154-157

9-N.Okçu, md. Onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Frequency of gastric carcinoma in Erzurum region, endoscopic and histological features. Gastroenterology 1994;5(2):263-267.

10-N. Okçu, MD Onuk, Tahir Buran, E. Akarsu, MA Çiftçioğlu. Frequency of Helicobacter Pylori in Nonspecific Gastritis Cases in Erzurum Province. Gastroenterology 1994;5(2):211-213.

11-N.Okçu, MD Onuk, Ö. Ünal, E. Akarsu, L. İncesu, K. Akgöz. Diagnostic Value of Ultrasound-Guided Fine Needle Aspiration Biopsy in Intra-Abdominal Mass Lesions. Gastroenterology 1993;4(1):166-68.

12-NOkçu, md. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Syndrome (2 Cases). Turkish J Gastroenterhepatol 1993; 4(1):77-80.

13-N.Okçu, H. Koçak, MD Onuk, M. Gündoğdu, E. Bakan, A. Yılmaz, A. Başoğlu, A. Ateş, F.A. Paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriuretic Peptide (ANP) Levels. Vascular Surgery 1993; 27(2): 128-132

15-N.Okçu, MD Onuk, A.Yılmaz, M. Gündoğdu, T. Buran. Effects of Omeprozole and Ranitidine on Peptic Ulcer Healing. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.

16-N. Okçu, Mr. Yiğitoğlu, B. Adam, E. Bakan. The Effect of Digixin on Plasma Atrial Natriuretic Peptic Level in Patients with Congestive Heart Failure. S.Ü. Medical Faculty Journal 1991;7(2):243-247..

17-N.Okçu, A. Yılmaz. The Effect of Histamine H2 -Receptor Antagonists in Upper Gastrointestinal System Bleeding. Endoscopy Journal 1991;2(4):17-23.

18-N.Okçu, E. Bakan, B. Adam, A. Yılmaz, Mr. Yiğitoğlu. Sex Hormones and Sex Hormone Binding Globulin Levels in Patients with Chronic Hepatitis and Liver Cirrhosis (Letter to the Editor). Nature-Tr. J. Of Medical Sciences 1991;15:1-2.

19-N.Okcu Ömer Yılmaz.Helıcobacter pylori and related gastrointestinal system diseases. Turkish Clinics JMed Sci. 2013;33(3):806-13

20-Nihat Okçu, Ömer Yılmaz, Hakan Dursun, Gülçin Polat. The relationship between dyspeptic symptoms, nutritional habits, endoscopic and histological findings (Eurasian J Med 2006; 38: 13-17)

21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayir,1Ibrahim Pirim,2Salim B. Tekin,1andCemal Gundogdu3 - Distribution of HLA Tissue Groups in Patients with Gastric Cancer Eurasian J Med. 2010 Apr; 42(1): 9.11.

22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu:The fibroblast proliferation, relationship of hepatocyte growth factor (HGF) and interferon-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404

23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sari,Nihat Okcu,Abdulhalim Baki. The effect of fish oil on stress ulcer prophylaxis GastroenterologyVolume 118, Issue 4, Part 2, PageA1255

EDUCATION:

2014 ADNAN MENDERES UNIVERSITY FACULTY OF MEDICINE, CHILD HEALTH AND DISEASES, CHILD NEUROLOGY

2011 IZMIR EDUCATION AND RESEARCH HOSPITAL, CHILD HEALTH AND DISEASES

2011 Izmir Tepecik Education and Research Hospital, Child Health and Diseases

2004 DICLE UNIVERSITY, FACULTY OF MEDICINE

EXPERIENCE:

2018 Istanbul Medipol Hospital

2017 - 2018 Kartal Education and Research Hospital

2014 - 2016 Denizli State Hospital

2011 - 2014 Aydin Adnan Menderes University Faculty of Medicine Hospital

2006 - 2011 Izmir Tepecik Education and Research Hospital

2011Izmir Education and Research Hospital

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

EDUCATION:

2009

Ankara Etlik Maternity Hospital and Gynecology Education and Research Hospital, Gynecology and Obstetrics

2003

Ankara University, Faculty of Medicine

EXPERIENCE:

2019 - to present

Medipol University Pendik Hospital

2009 - 2019

Yakacık Maternity and Child Diseases Hospital

PUBLICATIONS:

Articles Published in Journals Indexed in SCI, SSCI and AHCI

Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial

YİĞİT E., ÜNSAL S.

Climacteric , 2024 (SCI-Expanded)

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Licensed Radiation Oncologist with 8 years of medical training, including undergraduate studies at Marmara University Faculty of Medicine (2004-2011) and Radiation Oncology specialization training at Marmara University Faculty of Medicine (2012-2016). Previous education from Sixteen Numbered Shirvan School (Azerbaijan) High School (1998-2004).

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Assoc. Dr. Görkem TÜRKKAN started his medical education at Gülhane Military Medical Academy in 2003 and completed it in 2009 at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine. He completed his residency in the Department of Radiation Oncology at Trakya University Faculty of Medicine and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Doctor Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology from May 2019 to February 2021. During this period, between March and June 2020, he worked as a clinical researcher in the Department of Radiation Oncology at Maastricht University Medical Center–MAASTRO Clinic (Netherlands) on studies related to stereotactic radiotherapy, thoracic radiation therapy-associated lung toxicity, and proton therapy. Between March 2021 and April 2023, he worked at the Radiation Oncology Department of Istinye University Faculty of Medicine and Liv Hospital Ulus Radiation Oncology Clinic, where he received the title of Associate Professor in February 2023. He has been providing services to his patients at Hisar Hospital Intercontinental since May 2023.

Throughout his professional life, he has performed both traditional and advanced radiotherapy practices. Particularly, he is one of the experienced physicians in Turkey in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which are gaining popularity and usage recently. So far, he has successfully completed over 2500 radiotherapy sessions using the MR-Linac device.

Since 2013, he has been a member of the Turkish Radiation Oncology Society (TROD) and since 2015 a member of the European Society for Radiotherapy and Oncology (ESTRO). He has 27 published articles in national and international journals, 31 oral-poster presentations at national and international congresses, and 5 book chapters published by national and international publishers. He has taught undergraduate courses in Period I and Period V at Muğla Sıtkı Koçman University Faculty of Medicine, master’s courses within the ENT Department Specialist training, and Radiation Therapy associate degree courses at Istinye University Health Services Vocational School. He is currently involved in 2 ongoing TÜBİTAK Projects. He is married and has one son.

MEDICAL INTERESTS

• MR-Linac
• Linac
• Stereotactic (Precision) Radiotherapy
• Prostate Cancers
• Breast Cancers
• Lung Cancers
• Rectal Cancers
• Brain and Spinal Cord Cancers
• Head and Neck Cancers
• Volumetric Arc Therapy (VMAT)
• Intensity-Modulated Radiation Therapy (IMRT)
• 
   

Prof. Dr. Ümmügül Üyetürk completed her undergraduate and graduate education at Uludağ University Faculty of Medicine between 1988-1994. She specialized in Internal Medicine at Istanbul Training and Research Hospital from 1998 to 2003. Between 2008-2011, she received her subspecialty training in Medical Oncology at Ankara Oncology Training and Research Hospital.

After serving as the deputy chief physician at Suluova State Hospital, she established the Internal Medicine Department and Medical Oncology Science Branch at Bolu Abant İzzet Baysal University between 2011-2020, where she served as the head of the science branch. During this time, she educated resident doctors and students. Üyetürk, who received the title of Associate Professor in 2014, spent 6 months in Canada/Toronto in 2019. In 2020, she was awarded the title of Professor at Abant İzzet Baysal University.

Üyetürk has published over 60 articles in international peer-reviewed journals and has more than 20 scientific works published in national peer-reviewed journals. She also has over 100 presentations that have been delivered at international and national scientific meetings and published in proceedings books. In addition to her membership in the European Society for Medical Oncology, she has memberships in medical oncology associations within the country. She has received more than 10 awards given to her at universities and congresses.

MEDICAL INTERESTS

• Prostate Cancer and Urological Cancers
• Lung Cancer
• Gastrointestinal System Cancers
• Breast Cancer
• Ovarian, Endometrial, and Cervical Cancers (Genital Cancers)

Prof. Dr. Süleyman Alıcı completed his medical education at Atatürk University Faculty of Medicine. (1990) He later specialized in Internal Medicine between 1991-1995 at Selçuk University Faculty of Medicine Internal Medicine Clinic. He worked as an Assistant Professor at Yüzüncü Yıl University Faculty of Medicine Internal Medicine Clinic between 1996-1997. He obtained his subspecialty training in Medical Oncology at Istanbul University Faculty of Medicine (Çapa Medicine) between 1997-2000. After that, he worked again at Yüzüncü Yıl University Faculty of Medicine between 2000-2005 and established the Medical Oncology Department. He served as the head of the relevant department, providing training services to research assistant doctors and student education. He has supervised the theses of 2 research assistants in the internal medicine clinic. Alıcı, who received the title of Associate Professor in 2004, served as the clinical chief of the Medical Oncology Clinic at Ankara Atatürk Training and Research Hospital between 2005-2008. He was responsible for the formation and establishment of the Medical Oncology Clinic at the same hospital, providing training to Medical Oncology residents. In 2007, he received training and worked as an observer at Dana Farber Cancer Hospital and Massachusetts General Hospital in the fields of gastrointestinal tumors, breast cancer, and lung cancers (Thoracic Cancers).

Prof. Dr. Süleyman Alıcı, who took part in the opening and establishment of Medicalpark Göztepe Oncology Hospital (2008-2017), worked at Acıbadem Hospital/Altunizade Branch in the Medical Oncology Clinic between 2017-2023.

Alıcı has over 70 published articles in international peer-reviewed journals and over 50 scientific studies published in domestic peer-reviewed journals. He has presented over 100 papers at scientific meetings both domestically and internationally. In addition to his memberships in the European Society of Medical Oncology and the American Society of Clinical Oncology, he also has memberships in oncology associations within the country. He has received more than 10 scientific publication incentive awards from TÜBİTAK and some medical oncology associations.

His areas of interest include gastrointestinal cancers such as Stomach-Intestine, Pancreatic cancers, as well as Lung Cancers.

MEDICAL INTERESTS

Stomach Cancer
Intestinal Cancer
Lung Cancer
Ovarian Cancer
Breast Cancer
Esophageal Cancers